会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Methods and configurations of LC combined transformers and effective utilizations of cores therein
    • LC组合变压器的方法和配置以及其中的芯的有效利用
    • US09257225B2
    • 2016-02-09
    • US12166322
    • 2008-07-02
    • Chun LiJason (Jian Hao) LiRan Ran Li
    • Chun LiJason (Jian Hao) LiRan Ran Li
    • H01F21/04H01F27/28H01F21/02H01F27/38H01F3/12H01F38/16
    • H01F27/385H01F3/12H01F38/16
    • The LC combined transformer is a combination of capacitors, inductors and an electrically-isolated mutual inductor, i.e. conventional transformer; which in principle is a unity-coupled mutual capacitor or a cascade connection of an ideal transformer and unity-coupled mutual capacitor(s). To improve the imperfections of widely-used transformers, by employing the simplest passive-circuit design to attain a perfectly-functional match between mutual capacitors and the mutual inductor, this invention achieves optimal features of current or/and voltage transformation, and introduces a new function of waveform conversion from square to quasi-sine. The ideal current transformer herein is suitable for sinusoidal current measurements, the ideal voltage transformer herein suitable for sinusoidal voltage measurements, and they also could be upgraded to ideal transformers for both current and voltage transformations. This transformer can be designed as power transferable as well as waveform convertible, applicable in power systems or power electronics. Herein also states the design approach of integrated inductor and mutual inductor, and the use of push-pull inductor, materials being fully utilized and sizes decreased.
    • LC组合变压器是电容器,电感器和电隔离互感器的组合,即常规变压器; 其原理上是单相耦合互电容器或理想变压器和单相耦合互电容器的级联连接。 为了改善广泛使用的变压器的缺陷,通过采用最简单的无源电路设计,实现互电容和互感器之间的完美功能匹配,本发明实现了电流或/和电压转换的最佳特性,并引入了新的 从正方形到准正弦的波形转换功能。 本文中理想的电流互感器适用于正弦电流测量,本文中的理想电压互感器适用于正弦电压测量,并且还可升级为用于电流和电压转换的理想变压器。 该变压器可以设计为可转换的以及波形转换,适用于电力系统或电力电子设备。 这里还介绍了集成电感和互感器的设计方法,以及推挽式电感器的使用,充分利用材料和尺寸减小。
    • 6. 发明申请
    • BALLOON PRESSURE PUMP
    • 气压泵
    • US20140301867A1
    • 2014-10-09
    • US14124607
    • 2012-06-06
    • Chun LiYunxing Liu
    • Chun LiYunxing Liu
    • F04B45/02
    • A61M25/10181A61M25/1018A61M25/10188F04B45/02
    • A balloon pressure pump comprising a cavity (1) having a distal end and a proximal end; a push rod (2) having a distal end and a proximal end, and provided with an external thread and inserted into the cavity; a handle (3) fixedly connected with the proximal end of the push rod (2); a locking member (4) having a distal end and a proximal end and arranged on the proximal end of the push rod (2) and used to lock same; the distal end of the locking member (4) is fixedly connected with the proximal end of the cavity (1). The handle (3) is internally provided with a sleeve (5) to accommodate the push rod (2); said sleeve (5) is fixedly connected with the proximal end of the locking member (4). The proximal end of the push rod (2) includes a spring (11) which is enclosed within the sleeve. The simple structure of the pump simplifies operations such as pressure application, pressure relief, negative pressure evacuation and the like, and is greatly convenient for a user.
    • 一种球囊压力泵,包括具有远端和近端的空腔(1) 具有远端和近端的推杆(2),并且设置有外螺纹并插入所述空腔中; 与所述推杆(2)的近端固定连接的手柄(3); 锁定构件(4),其具有远端和近端并且布置在推杆(2)的近端上并且用于将其锁定; 锁定构件(4)的远端与空腔(1)的近端固定连接。 手柄(3)内部设置有套筒(5)以容纳推杆(2); 所述套筒(5)与所述锁定构件(4)的近端固定连接。 推杆(2)的近端包括封闭在套筒内的弹簧(11)。 泵的简单结构简化了压力施加,减压,负压抽空等操作,并且对用户非常方便。
    • 7. 发明授权
    • Nanoparticle formulated glycolipid antigens for immunotherapy
    • 纳米颗粒配制的糖脂抗原用于免疫治疗
    • US08546371B2
    • 2013-10-01
    • US13188642
    • 2011-07-22
    • Dapeng ZhouChun Li
    • Dapeng ZhouChun Li
    • A01N43/00A61K31/33
    • A61K39/39A61K2039/55511A61K2039/55555A61K2039/57
    • A composition for stimulating NKT cells to produce anti-cancer and anti-viral cytokines without causing anergy of NKT cells includes a glycolipid antigen and a nanoparticle conjugated with the glycolipid antigen. The glycolipid antigen and the nanoparticle are not antigenic in mouse and human being. The composition can further include covalent or non-covalent connection between the glycolipid antigen and the nanoparticle. The glycolipid antigen is alpha-galactosylceramide or an analog of that. The nanoparticle can be a polymer. A production method of the composition includes preparing a nanoparticle and a glycolipid antigen and loading the glycolipid antigen to the nanoparticle. The glycolipid antigen can be coated onto the surface of the nanoparticle or encapsulated within the nanoparticle. A method of stimulating NKT cells to produce anti-cancer and anti-viral cytokines without causing anergy of NKT cells is also provided.
    • 用于刺激NKT细胞以产生抗癌和抗病毒细胞因子而不引起NKT细胞的无反应性的组合物包括糖脂抗原和与糖脂抗原缀合的纳米颗粒。 糖脂抗原和纳米颗粒在小鼠和人中不是抗原性的。 组合物还可以包括糖脂抗原和纳米颗粒之间的共价或非共价连接。 糖脂抗原是α-半乳糖神经酰胺或其类似物。 纳米颗粒可以是聚合物。 组合物的制备方法包括制备纳米颗粒和糖脂抗原并将糖脂抗原加载到纳米颗粒中。 糖脂抗原可以涂覆在纳米颗粒的表面上或者包封在纳米颗粒内。 还提供了刺激NKT细胞以产生抗癌和抗病毒细胞因子而不引起NKT细胞的无反应性的方法。
    • 8. 发明授权
    • Transdermal patch containing isosorbide dinitrate and bisoprolol
    • 透皮贴剂含有硝酸异山梨酯和比索洛尔
    • US08071125B2
    • 2011-12-06
    • US12096545
    • 2005-12-09
    • Shuming WangLi WangXiaoling FanHuiyong XueShuang ZhangEnhong ZhangXuying ZhongYucheng LuChun LiLi Song
    • Shuming WangLi WangXiaoling FanHuiyong XueShuang ZhangEnhong ZhangXuying ZhongYucheng LuChun LiLi Song
    • A61F13/00
    • A61K9/7061A61K31/138A61K31/724
    • This invention relates to a transdermal patch in the form of a layer complex, comprising a backing layer, a drug-reservoir layer comprising pharmacologically active ingredients and pharmaceutically acceptable adjuvants, and a release liner covering the drug-reservoir layer, characterized in that the drug-reservoir layer comprises isosorbide dinitrate and Bisoprolol at a ratio of 1:3 to 3:1 by weight, as the pharmacologically active ingredients. Animal tests show that said patch can reduce the elevation of T wave of cardiogram, the increase of the level of myocardial enzyme in blood serum, and the extension of the range of myocardial infarction caused by ligating the coronary artery in animals. Results show that said patch exhibits a considerable synergistic effect in the treatment of cardiovascular diseases and has good preventive and therapeutic effects on several adverse events on heart. In addition, the animal tests show that the patch according to the invention has a better pressure-reducing effect than the application of the patch containing only one of isosorbide dinitrate and Bisoprolol, and does not worsen the arrhythmia that is easily caused by the application of the patch containing only isosorbide dinitrate or Bisoprolol.
    • 本发明涉及层复合物形式的透皮贴剂,其包含背衬层,包含药理活性成分和药学上可接受的佐剂的药物储库层,以及覆盖药物储库层的释放衬垫,其特征在于药物 作为药理活性成分,含有硝酸异山梨酯和比索洛尔,比例为1:3〜3:1。 动物试验表明,所述贴片可以降低心电图T波的升高,血清中心肌酶水平的升高,以及通过在动物中连接冠状动脉引起的心肌梗塞范围的延长。 结果表明,所述贴片在治疗心血管疾病方面具有相当大的协同效应,对心脏上的几种不良事件具有良好的预防和治疗作用。 此外,动物试验表明,根据本发明的贴剂具有比仅含有硝酸异山梨酯和比洛维罗之一的贴剂的施用更好的减压效果,并且不会使应用容易引起的心律失常恶化 该补丁仅含有硝酸异山梨酯或比索洛尔。
    • 9. 发明申请
    • LOCKING SYRINGE WITH INTEGRATED BIAS MEMBER
    • 具有集成的偏置构件的锁定注入
    • US20110071393A1
    • 2011-03-24
    • US12563002
    • 2009-09-18
    • Yunxing LiuChun Li
    • Yunxing LiuChun Li
    • A61B6/00A61M5/315
    • A61M5/31501A61B6/481A61B6/504A61M5/007A61M5/20A61M5/3129A61M5/3148A61M5/31505A61M5/31511A61M2005/3139A61M2005/31508
    • A locking syringe with an integrated bias member, for delivering medical fluids at high pressure, can include a housing, a shaft, a piston, a cap assembly, a bias member, and a locking member. A distal end of the housing can interface with a patient delivery apparatus. The housing includes an internal cavity into which a distal end of the shaft can be inserted. The piston can be connected to the distal end of the shaft and can include a peripheral sealing surface that can slidably engage the inside surface of the housing to form a movable seal. The cap assembly at the proximal end of the housing can engage the shaft. A base cap can secure the piston within the housing. The bias member can have a distal end coupled to the piston and a proximal end restrained, such as to help pressurize the internal cavity. The user-actuatable locking member can user-selectively engage and inhibit unwanted movement of the shaft.
    • 具有用于在高压下输送医用流体的集成偏压构件的锁定注射器可以包括壳体,轴,活塞,帽组件,偏置构件和锁定构件。 壳体的远端可以与患者输送装置接合。 壳体包括内腔,轴的远端可以插入其中。 活塞可以连接到轴的远端并且可以包括周边密封表面,其可滑动地接合壳体的内表面以形成可移动的密封。 在壳体的近端处的帽组件可以接合轴。 底盖可以将活塞固定在壳体内。 偏置构件可以具有联接到活塞的远端和约束的近端,例如帮助加压内部空腔。 用户可致动的锁定构件可以用户选择性地接合并阻止轴的不期望的运动。